---
tags:
  - '#audit'
  - '#cadrumo-product-rename'
date: '2026-07-14'
modified: '2026-07-17'
related:
  - "[[2026-07-12-cadrumo-product-rename-plan]]"
---

# `cadrumo-product-rename` audit: `W05.P13 documentation-workflow approval gate sign-off`

## Scope

The `W05.P13` documentation phase of the product-rename plan binds every step to
the `vaultspec-documentation` lifecycle, whose Phase 3 (refined wireframe) and
Phase 8 (final document) require sign-off from the authoritative approval gate.
Three independent reviews (the S68 README remediation audit, the S69 release
runbook audit, and the S72 site identity audit) returned FAIL solely because no
approval-gate evidence was on record; each assessed the content itself as
technically healthy. This document records the approval-gate adjudication and
sign-off for the phase's content set.

## Findings

### approval-authority | high | The approval gate for user documentation is the principal-writer session by standing operator directive

The operator directive of 2026-07-13 (docs-lifecycle-tutorials campaign)
designates the principal-documentation-writer session as the authoritative
approval gate for user documentation: it writes or approves final wording
directly, and delegation of that authority to dispatched subagents is
prohibited. The Phase 3 / Phase 8 sign-off demanded by the S68/S69/S72 reviews
is therefore this session's to grant, on the basis of a direct content review —
not a relayed campaign-level task authorization, which the reviewers correctly
rejected as insufficient.

### content-review | low | Direct review of the W05.P13 content set passes the product-authority naming law

The principal-writer session re-reviewed the phase's content at HEAD on
2026-07-14: `README.md` in full (product identity, name-boundary section,
worked Modelo 130 path, data-protection and disclaimer sections), the
`RELEASING.md` runbook head and release-blocker section, the site identity
configuration (`docs/conf.py` deriving `project` from the single
`PRODUCT_IDENTITY` authority), and a token sweep across `README.md`,
`RELEASING.md`, `docs/how-to`, `docs/explanation`, and `docs/reference` for
stale product-branding forms. Every surviving `aeat` token is either the
lawful CLI executable name or a genuine tax-authority referent; `Cadrumo`
prose casing and `CADRUMO` identity contexts conform to the
`cadrumo-cli-executable` decision. The apidocs drift gate reported a
conformant stub tree. No naming-law or content defect found.

### releasing-helper-warnings | low | The corrected release-helper warning blocks are approved as accurate against the live tooling

Commit `04552a7b52` additionally corrected two stale RELEASING.md warning
blocks that the S69 review had separately flagged as a content defect: the
release-apply and rollback helper descriptions claimed the `just` recipes
omitted companion versions, exact pins, and lockfile regeneration and printed
a broad tag push. The principal-writer session verified the rewritten blocks
against the live `justfile` recipes: the release-apply checklist enumerates
all seven release authorities including both companion versions and exact
pins, mandates `uv lock` / `uv lock --check` regeneration, and prints separate
named-tag pushes; the rollback recipe prints named rollback-tag pushes and all
three PyPI yank locations and executes nothing itself. The corrected wording
is accurate and is approved under the same Phase 8 authority as the rest of
the phase's content set.

## Recommendations

Phase 3 and Phase 8 sign-off is GRANTED for the `W05.P13` content set as
committed in `ba5bc9e033` (README, RELEASING, how-to, explanation/reference,
release checklist and template surfaces) together with the S72 site-identity
surfaces (`docs/conf.py`, product marks), subject to the phase's remaining
mechanical gates (S74 apidocs regeneration check, S75 full site build) passing.
Execution records for S68 through S73 should cite this audit as the
approval-gate evidence the earlier reviews found missing. The three FAIL
verdicts are resolved by this record; the content they assessed as healthy is
unchanged. Future documentation phases should record the approval-gate sign-off
at drafting time so independent review does not fail on process evidence alone.
